Background: When lactose malabsorption gives rise to symptoms, the result is called 'lactose intolerance'. Although lactose intolerance is often bothersome for patients, once recognized it may be managed by simple dietary adjustments. However, diagnosing lactose intolerance is not straightforward, especially in primary care. Aim: To summarize available evidence on the diagnostic performance of gastrointestinal symptoms and self-reported milk (lactose) intolerance in primary care, and the relationship between lactose malabsorption and intolerance. Data sources: PubMed, EMBASE and reference screening. Study selection: Studies were selected if the design was a primary diagnostic study; the patients were adults consulting because of non-acute abdominal symptoms; the diagnostic test included gastrointestinal symptoms and/or self-reported milk intolerance. A total of 26 primary diagnostic studies were included in the review.
Summary
Background: When lactose malabsorption gives rise to symptoms, the result is called 'lactose intolerance'. Although lactose intolerance is often bothersome for patients, once recognized it may be managed by simple dietary adjustments. However, diagnosing lactose intolerance is not straightforward, especially in primary care. Aim: To summarize available evidence on the diagnostic performance of gastrointestinal symptoms and self-reported milk (lactose) intolerance in primary care, and the relationship between lactose malabsorption and intolerance. Data sources: PubMed, EMBASE and reference screening. Study selection: Studies were selected if the design was a primary diagnostic study; the patients were adults consulting because of non-acute abdominal symptoms; the diagnostic test included gastrointestinal symptoms and/or self-reported milk intolerance. A total of 26 primary diagnostic studies were included in the review.
Data extraction: Quality assessment and data extraction were performed by two reviewers independently. They adhered to the most recent guidelines for conducting a diagnostic review as described in the Cochrane Diagnostic Reviewers' Handbook. Results: The diagnostic performance of diarrhea, abdominal pain, bloating, flatulence and selfreported milk intolerance was highly variable. A non-Caucasian ethnic origin was associated with the presence of lactose malabsorption. Both lactose malabsorbers and lactose absorbers reported symptoms during the lactose hydrogen breath test. Conclusions: Our review shows that high-quality studies on the diagnosis of lactose malabsorption and intolerance in primary care are urgently needed. An important prerequisite would be to clearly define the concept of lactose intolerance, as well as how it should be assessed.
Background
Lactose malabsorption is the most common type of carbohydrate malabsorption and is caused by low lactase levels. 1 Lactase activity is highest at birth and declines after weaning. The age at which this decline starts and the proportion of the adult population with lactase levels low enough to be considered having 'hypolactasia' are both strongly related to ethnicity, with highest rates of lactose malabsorption in Asian populations, Native Americans and African Americans (60-100%) and lowest rates in people of northern European origin and the US white population (2-22%). 2 When lactose malabsorption gives rise to symptoms, this is called 'lactose intolerance'. Although lactose intolerance is often bothersome for patients, once recognized it may be managed by simple dietary adjustments.
Diagnosing lactose intolerance is not straightforward. First, symptoms consistent with lactose intolerance (abdominal pain, bloating, flatulence and diarrhea) are common and may have many other causes. [3] [4] [5] [6] This is especially true for the primary care setting in many countries, due to its unselected population (i.e. absence of a referral filter). Irritable bowel syndrome, dyspepsia, inflammatory bowel disease, celiac disease and even malignancies are all part of the differential diagnosis. 7 Secondly, evidence on the diagnostic value of the symptoms consistent with lactose intolerance has not been systematically been reviewed yet. This evidence is highly needed, especially for primary care as signs and symptoms are the primary care physician's main diagnostic tools. Thirdly, the diagnostic value of self-reported milk intolerance is still a matter of debate; while on the one hand many more people seem to attribute their symptoms to lactose intake than objective testing is able to confirm, 3 on the other hand many patients fail to recognize an actual association. 7 Restriction of dietary lactose intake on the basis of self-reported milk intolerance without having been tested on lactose malabsorption may be unnecessary, if not detrimental to health. 8 Lastly, the lactose hydrogen breath test (LHBT) is currently considered to be the diagnostic method of choice, but actually identifies lactose malabsorption rather than lactose intolerance. 5 As both patients with a positive and patients with a negative LHBT result may report symptoms during a LHBT, the discrimination of lactose malabsorption from lactose intolerance is complex, as has also been demonstrated in a recently published study. 9 The aim of this review is to summarize all available evidence on the diagnostic value of gastrointestinal (GI) symptoms and self-reported milk intolerance. Additionally, we studied the relationship between lactose malabsorption and intolerance by analyzing the association between LHBT results and the presence of symptoms after lactose ingestion. In this review the setting of interest is primary care.
Methods

Data sources and searches
We searched PubMed and Embase for all eligible diagnostic studies (till November 2008). The search strategy used MeSH/EMTREE terms and free text words, and included sub-searches related to the index test, target condition, study population and publication type. A methodological filter for the identification of diagnostic studies was added to increase the specificity of the search. The full search strategies can be obtained from the corresponding author on request.
Reference lists of all retrieved primary diagnostic studies were checked for additional relevant studies. Additionally, references were checked of relevant reviews, meta-analyses, guidelines and editorials.
Study selection
Two authors (P.J. and F.S.) independently applied the pre-defined selection criteria (see below). P.J. checked all titles and abstracts, while F.S. checked eligibility of those assessed by P.J. as (possibly) relevant, as well as a random selection of citations assessed as not relevant. Full publications were retrieved for studies that seemed relevant and those for which relevance was still unclear. Disagreements were resolved by consensus. A third reviewer was consulted in cases of persisting disagreement.
Participants, setting and study design
We considered primary diagnostic studies relevant if the study population consisted of adults (!18 years) experiencing non-acute abdominal symptoms. Studies solely including persons with self-reported milk intolerance were excluded.
We intended to include only primary care studies, but due to the low number we decided to also include studies including patients visiting an outpatient GI clinic, as well as studies in which symptomatic adults had been recruited after population-based screening.
We included primary diagnostic studies with a cohort design, as well as case-control designs in which controls were diagnosed with functional bowel disorders or irritable bowel syndrome (IBS), as these may reflect an adequate representation of a primary care population with non-acute abdominal pain. For the same reason we included cohort studies in which all patients had been diagnosed with a functional bowel disorder or IBS, or casecontrol studies comparing IBS patients with healthy controls that presented diagnostic data for the IBS group separately. We excluded cohort studies in which all participants had an established organic diagnosis (e.g. inflammatory bowel disease), as well as other case-control study designs, case reports, editorials and papers written in other languages than English, Dutch, German or French. Authors of studies that did not present enough data to extract a diagnostic two-by-two table were contacted for additional data.
Reference test and target condition
Only studies using a LHBT as reference test were included. An LHBT is considered to be the most reliable, non-invasive, economical technique. 6 The formerly usual test dose was 50 g; however, a 25 g dose is usual in clinical practice and has recently been confirmed as the recommended dosage. 7, 10 Studies using duodenal biopsy or a lactose tolerance test with blood glucose measurements as the only reference test were excluded. Duodenal biopsy with assessment of lactase activity is considered to be a less rigid test than the LHBT, as disaccharidase activity in a small bowel biopsy specimen may not necessarily reflect the activity in the small bowel as a whole. 6 The lactose tolerance test with blood glucose measurements preceded the LHBT and is still sometimes used, but it is now recognized to yield an unacceptable number of both false-positive and false-negative test results. 1 We defined a positive LHBT result as lactose malabsorption, and a positive LHBT result plus accompanying clinical symptoms after the lactose load as lactose intolerance.
Index tests
Only studies on tests that can be carried out or are accessible in primary care were included, specifically: (i) presenting symptoms (before conducting the LHBT); (ii) self-reported milk intolerance; (iii) symptoms reported after lactose load (i.e. during the LHBT or immediately thereafter).
Data extraction and quality assessment
Data extraction and quality assessment were pre-tested using two studies not included in the review. Two authors (P.J., H.v.d.H.) used, independently from each other, a standardized form to extract data on setting and design; study population; test characteristics; and test results. Test results for healthy controls were not extracted. Quality was assessed by using a modified version of the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool, 1, 11 which is recommended by the Cochrane Diagnostic Reviewers' Handbook. 12 This modified version consists of 11 items on methodological characteristics that have the potential to introduce bias (Table 1) . Items were scored as 'positive' (i.e. no bias), 'negative' (i.e. potential bias) or 'unclear'. Inter-observer agreement was quantified by computing the percentage agreement per item; disagreements were resolved by consensus. We did not apply weights to the QUADAS items, nor used a summary quality score in the analysis. Instead, we decided, a priori, to explore whether scores on the following quality items explained variation in diagnostic performance: item 1 (validity of study sample), item 2 (blinded interpretation of results of index test) and item 5 (reference standard is likely to classify the target condition correctly).
Data synthesis and analysis
We present diagnostic two-by-two tables and diagnostic performance measures per research question. For the calculation of diagnostic performance measures and corresponding 95% confidence intervals (CIs) per study, we used MetaDiSc statistical software. 12, 13 When appropriate, we additionally present the results of pairs of sensitivity and 1-specificity in a scatterplot. When four or more studies on a specific index test showed sufficient clinical and statistical homogeneity we used bivariate analyses to calculate pooled estimates of sensitivity and specificity and 95% CIs for the summary estimates. 14, 15 Bivariate analyses take into account both within-and between-study variability, and perform better than SROC regression models derived with the Moses and Littenberg method, which departs from a fixed effects model. 16 We refrained from pooling when there was considerable statistical heterogeneity.
Investigations of heterogeneity
Factors that may contribute to variation in diagnostic performance across studies (heterogeneity) included differences in (i) setting of care: primary care vs. other; (ii) low vs. prevalence of lactose malabsorption using 30% as cut-off; (iii) exclusion from the study of patients with organic disease: yes vs. no; (iv) oral lactose load of 50 g vs. other load; (v) cohort study vs. (nested) case-control study design; (vi) QUADAS items 1, 2 or 5 (as described above).
Subgroup analyses were only performed when each subgroup included data of at least two diagnostic studies. In case each subgroup included data of at least four studies with homogenous results per subgroup, we calculated per subgroup a pooled estimate of sensitivity and specificity using bivariate analyses. In case subgroups included data of less than four studies or data of at least four studies showing heterogeneous results on visual inspection, we presented per subgroup the range of sensitivity and specificity. Studies providing insufficient information on a factor were not included in that specific subgroup analysis.
Results
Literature search and study selection
The literature search yielded 695 references. A total of 114 full papers were retrieved of which 25 were considered relevant for the review. 8, Reference checking yielded two additional relevant papers. 41, 42 With two papers reporting on the same study, 37 ,38 a total of 26 primary diagnostic studies were included in the review. A summary of the search results is presented in Figure 1 .
To enable extraction of a two-by-two table, authors of 11 papers were asked for additional data. 21, 25, 26, 32, 41, [43] [44] [45] [46] [47] [48] Five of them were able and willing to grant our request. 21, 25, 26, 32, 41 Study characteristics Table 2 presents details of the primary diagnostic studies included in the review. None of the studies were performed in primary care, while two studies were population-based screening studies. 25, 33 All but one 23 studies were cohort studies with prevalence of lactose malabsorption ranging from 4% 25 to 86%. 35 In 13 studies patients with organic diseases were explicitly excluded. 17, 19, 20, [23] [24] [25] 31, 32, 34, 35, 39, 41, 42 The following index tests were studied: (i) symptoms as presented before the LHBT (11 studies); (ii) self-reported milk intolerance or degree of milk consumption (nine studies); and (iii) symptoms as reported during the LHBT and immediately thereafter (18 studies). In 5 of the 26 studies, LHBT was not the single reference standard to diagnose lactose malabsorption; these studies additionally used the results of methane excretion, a lactose tolerance test, biopsy, diet, X-ray. 19, 23, 25, 27, 33 An oral lactose load of 50 g was used in 18 studies, [18] [19] [20] [21] [22] 24, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] while the dose was not reported in one study. 23 
Methodological quality of included studies
On average, the reviewers disagreed in 3 out of 11 items (range 1-6). Disagreements mainly concerned test review bias (item 2) and clinical review bias (item 4). All disagreements were resolved during consensus meetings. Table 3 presents the results of the quality assessment. Potential sources of bias most frequently related to the selection of study participants (item 1), clinical review bias (item 4), and the validity of the reference standard (item 5). The following aspects were poorly described (i.e. score 'unclear'): test review bias (item 2) and blind interpretation of reference test results (item 8). Generally, nine studies performed well receiving a positive assessment of at least 8 out of 11 QUADAS items. 18, 22, 27, 30, 32, [34] [35] [36] [37] Pre-test GI symptoms Table 4 presents the results of the 10 cohort studies and 1 case-control study that investigated the diagnostic performance of GI symptoms as presented before the LHBT test. Diarrhea, abdominal pain, bloating/distention, flatulence and constipation were investigated in at least four studies. Seven studies additionally reported on the diagnostic value of age, ethnicity or gender.
All four symptoms frequently associated with lactose intolerance showed very heterogeneous test results. For diarrhea 19, [22] [23] [24] 31, 34, 40 sensitivity ranged from 0.30 to 0.80 and specificity from 0.32 to 0.84; for abdominal pain 19, 22, 24, 31, 32 from 0.00 to 0.85 and from 0.18 to 0.73, respectively; for bloating [22] [23] [24] 32, 37 from 0.00 to 0.84 and from 0.18 to 0.96, respectively; for flatulence [22] [23] [24] 32 ,37 from 0.10 to 0.90 and from 0.08 to 0.89, respectively. Due to this heterogeneity we refrained from statistical pooling. In the category 'other GI symptoms' (Table 4) constipation 23, 24, 31, 40 or alternating diarrhea and constipation, 24 ,40 considered indicative of IBS, appeared to be often absent in those with lactose malabsorption (range sensitivity 0.00-0.22), but also in those without lactose malabsorption (range specificity 0.75-0.94). Statistical pooling of the four studies on constipation resulted in a sensitivity of 0.13 (95% CI 0.07-0.23) and a specificity of 0.83 (95% CI 0.75-0.89). Of the sociodemographic variables specificity of ethnicity was high ranging from 0.77 to 0.96, indicating that a non-Caucasian ethnic origin may be associated with the presence of lactose malabsorption. 18, 22, 24, 37 Self-reported milk intolerance Table 4 presents the results of the studies that investigated the diagnostic performance of self-reported milk intolerance (seven studies) or degree of milk consumption (three studies). Eight studies were cohort studies; 8, 19, 20, 22, 25, 26, 30, 35 one a case-control study. 23 As results for sensitivity ranged from 0.30 to 0.71, and for specificity from 0.25 to 0.87, we had to refrain from statistical pooling. The risk for lactose malabsorption among those with self-reported milk intolerance or reporting no or less milk consumption ranged from 0.62 to 0.92, while the risk among those reporting to be milk tolerant or had (normal) milk consumption varied from 0.32 to 0.79. The values reported by Farup et al. 25 are, however, much lower (0.06 and 0.03, respectively). In this screening-based study, the prevalence of lactose malabsorption (4%) was substantially lower than in the other studies (40-86%). Table 4 presents the results of 18 studies that investigated the relationship between symptoms after lactose ingestion and the results of the LHBT. All were cohort studies; none were performed in a primary care setting.
Lactose intolerance vs. malabsorption
About 33-97% of the patients with a positive LHBT result reported symptoms after lactose 
ingestion (sensitivity). We defined these as lactose intolerants. On the other hand, 0-71% of the lactose absorbers also appeared to report symptoms (1-specificity). Except for three studies 18, 25, 27 , the presence of symptoms after lactose ingestion was more strongly associated with a positive than a negative LHBT result [range positive predictive value (PPV) 0.54-1.0]. For the three studies in which this was not the case (i.e. PPV < 0.50), the presence of lactose malabsorption among those with symptoms after lactose ingestion was still about three times more likely than among those without symptoms after lactose ingestion [PPV/ (1 À NPV)].
Pre-planned subgroup analyses
Due to lack of data in one or both response categories many pre-planned clinical and methodological subgroup analyses could not be performed. In Table 5 , the results are presented for the subgroup analyses for which sufficient data were available. For none of the subgroup analyses the results for both sensitivity and specificity were sufficiently homogeneous to calculate pooled estimates. The factor 'validity of the study sample' (QUADAS item 1), however, seemed to explain some of the variation in diagnostic performance across studies: two studies 22, 32 with a valid study sample reported higher values for sensitivity but lower values for specificity of abdominal pain compared to the other two studies.
19,31
Discussion
The diagnostic performance of symptoms reported to be associated with lactose intolerance (diarrhea, abdominal pain, bloating and flatulence) was highly variable. More firm associations were found for ethnicity: lactose malabsorption is more likely when a patient is of non-Caucasian ethnic origin. Selfreported milk intolerance and occurrence of symptoms during LHBT were not only found in lactose malabsorbers but also in lactose absorbers. Overall, however, their presence is more often associated with lactose malabsorption than absorption.
Diagnostic performance of tests in primary care
Our systematic review cannot provide evidence that is directly relevant for primary care physicians, as none of the studies were performed in primary care populations. This is remarkable as in many countries patients will first present their lactose related symptoms to a primary care physician, with most of them being subsequently managed in primary care. In general, performance of diagnostic tests in secondary care is not easily transferable to primary care. Especially the predictive values of a test are strongly dependent on the prevalence of disease. In a setting with a low disease prevalence the same combination of sensitivity and specificity will lead to much lower positive predictive values compared with a setting with a high disease prevalence. Prevalence rates in the retrieved studies were remarkably high; 13 of the 26 studies reported prevalence rates of 50% or higher while only two studies reported a rate of <20%. 25, 31 Explanation for these high rates may be the studies' care setting, their strict in-and exclusion criteria, and the countries in which the studies were performed (see Discussion section).
Potential sources of bias
A first potential source of bias is the patient population included in the individual studies. In many studies (extensive) diagnostic work-up was used to exclude all possible organic diseases, which left a study sample consisting of patients with functional bowel disorders. As the presenting symptoms of patients with functional bowel disorders will be more homogeneous than the symptoms of all patients consulting for non-acute abdominal symptoms, the diagnostic performance of the presenting symptoms may be negatively influenced. Furthermore, by excluding all patients with organic disease the study design is actually changed from a cohort design into a nested case-control design, with accompanying consequences for prevalence rates. To investigate the potential bias of explicit exclusion of patients with organic disease we performed a subgroup analysis. Unfortunately, the results within the response categories were still too heterogeneous to pool the results. Finally, the so-called referral filter may have biased the diagnostic performance of self-reported milk intolerance; study populations of individual studies may have solely been composed of patients for whom this relationship was unclear as patients for whom there was not diagnostic uncertainty may not have been referred.
A second potential source of bias concerns the way tests were performed in the individual studies. Vernia et al. 8 mentioned that symptoms were trivial in most instances and that the occurrence of symptoms was likely to be overestimated as patients were encouraged to report 'any' symptom. This may have influenced the diagnostic performance of GI symptoms and the relationship between lactose malabsorption and intolerance. The use of a 50-g test dose has been criticized, especially for studies investigating symptoms, because it is equivalent to four to five servings (1 l of milk) which is far more than an individual usually ingests at one time. 49 We studied the influence of lactose load on the relationship between self-reported milk intolerance and lactose malabsorption, as well as between symptoms during the LHBT and lactose malabsorption. Although the results within the response categories were still too heterogeneous to pool, we believe that an 'overload' of 50 g is necessary to obtain reliable test results for detecting lactose malabsorption. In lactose malabsorbers this load guarantees that intestinal processes will not be able to compensate for the low lactase levels, while this load should not bother lactose absorbers. In those diagnosed with lactose intolerance (i.e. those with a positive LHBT result and reporting symptoms during the test), an important next step is the determination of each individual's threshold lactose dose in order to introduce that dose in the diet. 35 However, a 50 g lactose load could lead to relatively high numbers of 'false-positive' tests necessitating further diagnostic testing in a large number of subjects. The recommended dosage of 25 g 10 is therefore an acceptable compromise. One may also comment on the LHBT itself, which is currently considered to be the diagnostic method of choice. However, as lactose intolerance is of greater clinical interest than lactose malabsorption, one may argue that it would clinically be more relevant to use 'report of symptoms during a positive LHBT result', or 'disappearing of symptoms by a long-term lactose restricted diet after a positive LHBT' as reference standard in diagnostic accuracy studies.
The final potential source of bias we like to discuss is the country in which the study was performed. As mentioned before, prevalence rates of lactose malabsorption are strongly related to ethnicity. Indeed, in our review we found high specificity values for non-Caucasian populations. Additionally, higher prevalence rates were found in studies performed in Mediterranean countries (n = 8, range 39-86%) compared to those performed in Northwestern Europe (n = 6, range 4-40%). Considering these differences one should be very cautious to generalize findings across countries. Additionally, one would expect different clinical routine across countries, with lactose breath testing more generally implemented in Mediterranean countries than in Northwestern Europe.
Strength and weaknesses review
In this review, where possible we adhered to the most recent guidelines for conducting a diagnostic review as described in the Cochrane Diagnostic Reviewers' Handbook. We used an extensive search strategy, but included a methodological filter to increase its specificity. By reference checking we tried to track down those publications our search strategy had failed to identify. We took into account the generally poor reporting of diagnostic accuracy studies 50 by excluding quality assessment scores 'unclear' from methodological subgroup analyses for the QUADAS tool.
The inclusion criteria of our review reflect our priority for gathering diagnostic performance data that are relevant to clinical practice. We solely extracted or reconstructed diagnostic data collected from symptomatic patients, excluding information from healthy controls. This decision resulted in less favorable results for specificity than sometimes presented in the original publications, or even led to exclusion of studies. Our inclusion criteria were strict in order to increase clinical relevance of the review, but the criteria also permitted us to include studies that were conducted with another research objective but fulfilling our criteria and providing enough data for a relevant diagnostic two-by-two table. We also used strict criteria to define our target disease. We defined lactose malabsorption as a positive LHBT result, thereby excluding literature on lactose malabsorption as defined by a positive blood glucose tolerance test. Whereas lactose intolerance appears to be imprecisely defined in medical literature-in several reviews lactose malabsorption and intolerance were used as synonyms-we decided to define lactose intolerance as a combination of a positive LHBT result (i.e. lactose malabsorption) plus accompanying clinical symptoms. Although this definition may not be generally applied, we believe that use of explicit and clinically meaningful definitions are inevitable if one wants to gather evidence on its diagnosis.
Conclusion and recommendations
As diagnostic performance of GI symptoms reported to be associated with lactose malabsorption was highly variable and as primary care studies were lacking, we were unable to draw firm conclusions for clinical practice. Given the inconsistent diagnostic results of self-reported milk intolerance, our review provides no evidence that patients with self-reported milk intolerance should all be prescribed a lactose-restricted diet. High-quality studies on the diagnosis of lactose malabsorption and intolerance in primary care are clearly needed. The study population should consist of patients who consult their primary care physician for GI symptoms, regularly use milk products and for whom no strong clinical suspicion exists for other organic diseases (such as colorectal cancer, inflammatory bowel disease, etc.). Inclusion of healthy controls is not useful if results are to be relevant to clinical practice. Such a study will result in less favourable, but much more realistic values for a test's specificity, and positive and negative predictive values. An important prerequisite of the study would be to clearly define the concept of lactose intolerance (e.g. a positive LHBT result plus accompanying clinical symptoms), as well as how it should be assessed. Only then clinically relevant research questions for which evidence is highly needed, can be studied, such as 'Which pre-test GI symptoms are useful in diagnosing lactose intolerance?'.
